In addition, it was shown that HMGB3 protein could bind to chemotherapeutic drug–induced damage DNA, leading to the activation of ATM‐and Rad3‐related protein, thus promoting the drug resistance of tumor cells (Mukherjee et al., 2019; Jiang et al., 2020). This evidence concerns the gene ATM and neoplasm.